Humanization of antibodies

Details for Australian Patent Application No. 2004280333 (hide)

Owner MedImmune, Inc.

Inventors Damschroder, Melissa; Wu, Herren; Dall'Acqua, William

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004280333

PCT Pub. Number WO2005/035575

Priority 60/510,741 13.10.03 US; 60/497,213 22.08.03 US

Filing date 20 August 2004

Wipo publication date 21 April 2005

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/035575 Priority application(s): WO2005/035575

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280342-Mar-resistant oligomeric-based coatings for glass-plastic glazing products

2004280329-Synthetic polysaccharide antigens for immunological intervention in disease